Abacus Health Products Inc.

Abacus Health Products in its $34 million financing

Client

Abacus Health Products Inc.

Value

$34 million

Service

Capital Markets

Date Closed

May 2019

Lead Office

Montréal


On May 8, 2019, Abacus Health Products announced the closing of its $34 million bought deal offering. The offering was underwritten by a syndicate of dealers led by Eight Capital and including GMP Securities LP, Cormark Securities Inc., Haywood Securities Inc. and Paradigm Capital Inc. Abacus Health Products intends to use the net proceeds to accelerate the company's marketing and sales programs, increase its retail pharmacy store location and advance the international distribution of its products.

Abacus Health Products, based in Toronto, Canada, manufactures and sells over-the-counter (OTC) topical formulations infused with cannabidiol (CBD) extracted from hemp.

Osler, Hoskin & Harcourt LLP represented Abacus Health Products with a team consisting of Eric Levy, Jason Comerford, Bastien Gauthier, Jeremy Brisset, Jie Chai, Jean-Philippe Bertrand (Corporate), Manon Thivierge and Kevin Colan (Tax).

 


Team
Eric M. Levy
Key Contact

Eric M. Levy

Partner, Corporate

Jason  Comerford

Jason Comerford

Partner, Corporate

Bastien  Gauthier

Bastien Gauthier

Partner, Corporate

Jeremy Brisset

Jeremy Brisset

Associate, Corporate

Jie Chai

Jie Chai

Associate, Corporate

Jean-Philippe Bertrand

Jean-Philippe Bertrand

Associate, Corporate

Manon Thivierge

Manon Thivierge

Partner, Taxation

Kevin Colan

Kevin Colan

Counsel, Taxation